LABORATORY RESEARCH SUMO-Specific Protease 1 Promotes Prostate Cancer Progression and Metastasis Researchers showed that SUMO-specific protease 1 expression directly correlates with prostate cancer aggressiveness and reccurrence, by analyzing more than 150 prostate cancer specimens. [Oncogene] Abstract Aberrant Expression of the Neuronal-Specific Protein DCDC2 Promotes Malignant Phenotypes and Is Associated with Prostate Cancer Progression By integrating gene profiling and immunohistochemical data with functional experiments in cell lines, investigators showed that doublecortin domain containing 2 (DCDC2) is aberrantly expressed in prostate tumors whereas absent in normal prostate. [Oncogene] Abstract Prostaglandin E2 Stimulates S100A8 Expression by Activating Protein Kinase A and CCAAT/Enhancer-Binding-Protein-Beta in Prostate Cancer Cells Scientists showed that S100A8 and to a lesser extent S100A9 mRNA expression is induced by prostaglandin E2 in a dose and time-dependent manner in PC-3 prostate cancer cells as well as in BPH-1 benign prostatic epithelial cells. [Int J Biochem Cell Biol] Abstract Estrogen Promotes Prostate Cancer Cell Migration via Paracrine Release of Enolase 1 from Stromal Cells Scientists observed that conditioned medium from estradiol-stimulated prostate stromal cells significantly promoted the migration of prostate cancer cells. [Mol Endocrinol] Abstract NGF/γ-IFN Inhibits Androgen Independent Prostate Cancer and Reverses AR Function through Down Regulation of FGFR2 and Decrease in Cancer Stem Cells Investigators explored the inhibitory effect of a cytokine environment on androgen independent prostate cancer and its mechanism. [Stem Cells Dev] Abstract Molecular Expression and Functional Activity of Sodium Dependent Multivitamin Transporter in Human Prostate Cancer Cells Researchers characterized sodium dependent multivitamin transporter in human derived prostate cancer cells. [Int J Pharm] Abstract Effect of Diallyl Disulfide on Insulin-Like Growth Factor Signaling Molecules Involved in Cell Survival and Proliferation of Human Prostate Cancer Cells In Vitro and In Silico Approach through Docking Analysis Researchers evaluated the effects of diallyl disulfide on insulin like growth factor signaling in androgen independent prostate cancer cells. [Phytomedicine] Abstract Artepillin C (3,5-Diprenyl-4-Hydroxycinnamic Acid) Sensitizes LNCaP Prostate Cancer Cells to TRAIL-Induced Apoptosis Investigators determined the mechanisms by which tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) resistance can be overcome in prostate cancer cells by artepillin C. [Int J Oncol] Abstract | Full Article Neuropeptide-Inducible Upregulation of Proteasome Activity Precedes Nuclear Factor Kappa B Activation in Androgen-Independent Prostate Cancer Cells Upregulation of nuclear factor kappa B activity and neuroendocrine differentiation are two mechanisms known to be involved in prostate cancer progression to castration resistance. Researchers investigated for evidence of a direct mechanistic connection between these pathways with the use of immunocytochemistry, western blot analysis, electrophoretic mobility shift assay and proteasome activity assessment. [Cancer Cell Int] Abstract | Full Article CLINICAL RESEARCH Long-Term Disease-Specific Functioning Among Prostate Cancer Survivors and Noncancer Controls in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Within the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial, scientists assessed the long-term disease-specific functioning among prostate cancer survivors versus noncancer controls, the impact of trial arm on functioning, and the effect of treatment modality on functioning. [J Clin Oncol] Abstract Feasibility of Holmium Laser Enucleation of the Prostate (HoLEP) for Recurrent/Residual Benign Prostatic Hyperplasia (BPH) Scientists assessed the technical feasibility, functional outcome and morbidity of HoLEP for symptomatic BPH in patients with previous transurethral prostate surgery. [BJU Int] Abstract Testosterone Recovery in the Off-Treatment Time in Prostate Cancer Patients Undergoing Intermittent Androgen Deprivation Therapy Scientists studied intermittent androgen deprivation for prostate cancer with the objective of reducing the side effects of treatment and potentially delaying the development of hormone resistance. [Prostate Cancer Prostatic Dis] Abstract |